sp² magazine provides its highly targeted readers with the best blend of up-to-date business news, interesting technical content and opinion from industry leaders in an easy to read format.

Developments in technologies including genomics, proteomics, medicinal chemistry, combinatorial chemistry, asymmetric chemistry, catalysis, biocatalysis, fermentation and whole cell techniques are revolutionising the production of new chemical entities, investigational new drugs and established generic active ingredients.

sp² was launched specifically to address this change and is the only magazine with a newly compiled bpa audited circulation, custom-built to communicate your message to the buyers and specifiers you want to reach.